---
title: "Weekly Recap | VEA.US -1.22%, outpacing the S&P 500"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302163044.md"
description: "VEA.US fell 1.22% this week to close at $69.49, versus a prior close of $70.35. The S&P 500 dropped 1.95%, leaving the ETF roughly 0.73 percentage points ahead. The daily bars show a choppy path: Monday opened at $70.18, Wednesday slipped to a $69.11 low, Thursday traded down to $68.82 before recovering to $69.66, and Friday settled at $69.49. The overall tone was a pullback followed by range-trading, with a weekly range of 2.02%."
datetime: "2026-10-17T05:08:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302163044.md)
  - [en](https://longbridge.com/en/news/302163044.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302163044.md)
generator: "portal-rs"
---

# Weekly Recap | VEA.US -1.22%, outpacing the S&P 500

## The Week

VEA.US fell 1.22% this week to close at $69.49, versus a prior close of $70.35. The S&P 500 dropped 1.95%, leaving the ETF roughly 0.73 percentage points ahead. The daily bars show a choppy path: Monday opened at $70.18, Wednesday slipped to a $69.11 low, Thursday traded down to $68.82 before recovering to $69.66, and Friday settled at $69.49. The overall tone was a pullback followed by range-trading, with a weekly range of 2.02%.

## Sector News

This week’s news flow centred on AI investment and the healthcare sector. HSBC launched discretionary investment portfolios for retail clients, while its executives warned that AI financing faces stricter scrutiny and investors are demanding higher returns; the bank also said it would double its Hong Kong AI team to 300. AstraZeneca struck an AI drug discovery partnership with insitro worth up to $1.86bn, helping lift innovative drug names and driving the Hang Seng Innovative Drug ETF up more than 4%. In US trading, money rotated into defensive health-care stocks, with Eli Lilly up over 4%. Elsewhere, fears of a UK bank tax ahead of the budget pressured London-listed lenders, while Royal Bank of Canada rose in pre-market action.

## The Week Ahead

The macro calendar features the US NAHB housing market index on Monday 19 October, with both the prior and forecast at 32. Tuesday 20 October brings housing starts at an annualised rate, with the prior at 1.275m units and the forecast at 1.305m, alongside building permits. Wednesday 21 October sees the EIA weekly crude oil inventory and Cushing crude oil inventory. These releases should add texture to risk appetite and cyclical sentiment across developed markets.

## In Short

VEA.US edged lower but outperformed the S&P 500. Sector news remained busy on AI and healthcare, with HSBC’s call for higher returns on AI investment contrasting with AstraZeneca’s deeper push into AI-driven drug discovery. On the flows side, the latest session showed large-lot money as a net seller, pointing to lukewarm institutional participation in this broad developed-market ETF. The week ahead hinges on whether US housing data can lift cyclical sentiment and whether the AI theme holds across both banking and pharma.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [VEA.US](https://longbridge.com/en/quote/VEA.US.md)

## Related News & Research

- [Major Insider Move at IDT Sends Shockwaves Through the Market](https://longbridge.com/en/news/302157068.md)
- [TSMC Says AI Chip Demand Is Still Far Above What It Can Supply. That's Why I'd Buy Nvidia Stock.](https://longbridge.com/en/news/302159972.md)
- [Apple’s updated App Store rules go after ‘nudify’ AI apps](https://longbridge.com/en/news/302152749.md)
- [Top AXIA Energia Insider Makes a Major Move in the Market](https://longbridge.com/en/news/302157032.md)
- [Open-weight models win hearts, minds, and wallets](https://longbridge.com/en/news/302152719.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**